Lindy Biosciences develops formulation technology enabling high-concentration, low-viscosity suspensions of biologics for subcutaneous injection.
Location: United States, North Carolina, Durham
Employees: 11-50
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Next Act F... | nextactfun... |
| - | Charleston... | chapsc.com |
| - | BlueTree A... | bluetreeal... |
| - | Good Growt... | goodgrowth... |
Mentions in press and media 3
| Date | Title | Description |
| 29.02.2024 | NCBiotech awards $1.5 million in grants, loans in latest quarter | The North Carolina Biotechnology Center awarded 19 grants and loans totaling more than $1.5 million to universities, bioscience companies and non-profit organizations in the second quarter of its fiscal year. The awards, made in October, No... |
| 23.01.2019 | Lindy Biosciences Raises $547,000 in Equity | Lindy Biosciences, a Research Triangle Park-based therapeutics company, has raised $547,000 in equity. According to the Form D filed Tuesday, Lindy Biosciences must collect over $1 million in addition to sell its entire offering of $1.6 mil... |
| 22.03.2018 | Durham-based Lindy Biosciences Raises $150,000 | Lindy Biosciences has raised $150,000, according to a filing with the Securities and Exchange Commission. The money was raised by a single investor. The Durham-based company produces development-stage protein therapeutic formulations. Its c... |